Latest One Wales decisions
- 26/07/2021
- Azacitidine for progressive angioimmunoblastic T-cell lymphoma (OW16)
-
-
-
Last review date: September 2023
- 24/05/2022
- Mepolizumab (Nucala®) for chronic eosinophilic pneumonia (OW15)
-
-
-
Last review date: August 2023
- 24/05/2022
- Rituximab for pemphigus and pemphigoid (OW10)
-
-
-
Last review date: July 2023
- 12/04/2022
- Sorafenib for acute myeloid leukaemia (AML) maintenance (OW18)
-
-
-
Last review date: June 2023